Latest Australian Manufacturing News

AdAlta has met a key US$1 million milestone payment under its China collaboration, gaining critical clinical data and securing proprietary materials for Australian manufacturing of its lead CAR-T therapy BZDS1901.

SDI Limited’s acquisition by Beijing Guoci subsidiary is now effective following New South Wales Supreme Court approval, with the ASX suspension commencing and cash payout scheduled for early July.

Firebird Metals has placed all critical equipment orders for its Perth-based Australian Demonstration Plant, triggering the first ARENA grant payment and setting the stage for a pivotal 90-day fabrication phase. The project remains on track for early Q4 2026 equipment delivery, with imminent lithium manganese rich cathode results expected from its China pilot plant.

Biome Australia has inked a binding deal with Specialty Probiotics Australia to shift its Activated Probiotics manufacturing onshore, aiming to boost gross margins above 65% and streamline working capital within 18 months.

Tourism Holdings Limited (THL) has received a revised acquisition proposal from a BGH-led consortium offering NZ$3.10 per share. Meanwhile, THL has downgraded its FY26 profit guidance and raised its net debt forecast amid ongoing global travel uncertainties.

AdAlta has engaged specialist advisors to streamline US FDA regulatory processes for its CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients.

SDI Limited's acquisition by Beijing Guoci's subsidiary advances with ASIC registration of the scheme booklet and court approval to convene a shareholder meeting. The all-cash offer at a 53–58% premium awaits shareholder and final court approval.

MyEco Group is rolling out a new 95% post-consumer recycled bin liner range, fully certified under the Global Recycled Standard, exclusively at Woolworths stores nationwide from late May 2026. This move doubles its Woolworths product lineup and aligns with national sustainability targets.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Firebird Metals has locked in a purpose-built industrial facility in Osborne Park, Perth, to house its pioneering Australian Demonstration Plant, the only fully integrated manganese concentrate-to-cathode active material facility outside China.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

AdAlta has secured Australian manufacturing for its lead CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients. This move is a key step toward local clinical trials and boosts the therapy’s global commercial appeal.